Scott: And I've listened, Joe. So, what I'm saying
Post# of 36537
(Total Views: 259)
Posted On: 12/30/2019 2:19:17 AM
Scott: And I've listened, Joe. So, what I'm saying is if you were to take--and just
hear me out, and if you don't want to do it, fine--if you were to take your
existing footprint on Excellagen, where you're approved to sell what you
think you're going to sell in 2020. If that number were a thousand vials of 3
cc at 5700 gross margin and you were to put out a PR Monday saying, "We
think our 2020 bare minimum Excellagen sales are going to be this," and
there was a number like a thousand of those at 5700 bucks gross margin, I'd
go out and celebrate--and a lot of other people would too.
Joe: Well, you know what companies do that? Are companies on the OTC that are a sham company, that typically do things like that. I cannot, in good
conscience, do anything like that unless I'm fully funded, unless these
companies get the necessary dollars to fully execute on their plan or...
[crosstalk] Until that happens, I am not going to hypotheticalize on what
potential sales could be.
Scott: I'm not asking for hypotheticals. You are stocking your shelves with a
product, correct? You have said you have sales from Excellagen, correct?
You have that manufactured...
Joe: Again, as of right now, that would be very hard for me to gauge because I
don't... am I going to have--you tell me, am I going to have 20 VAs with the
money, am I going 50 VAs...?
Scott: That was what I'm saying, just tell us, "Worst case... here's what we’ve
gotten..."
Joe: I can't tell give that to you.
Scott: You don't have to tell me now, but if I have an asset that I'm producing for a
company that is not able to... where else are we producing revenues?
Joe: Listen, I appreciate what you're trying to make me do, but I'm not going to
hypotheticalize what we could do based upon so many different variables at
this point. I'd like to get the money in, full-funded, and then I'll project based
upon having all the money necessary to give you what you want in a forecast.
Scott: Okay. So, how long after we get the S-1 through do you think that would
happen, that we'd see something that says, "Here's what we're projecting."?
You've said that you think 250 million--
Joe: I don't know... it would be a guess. I don't know. How long will the STC take
to review the S-1 and then render it effective? I don't know.
Scott: No, I'm saying once you have the S-1, the 40 to 70 million is in the bank, do
you think that you'll put out a projection in X weeks, X months after...
Joe: If we are fully funded, I would out projections pretty immediately, because
then I know--I know already what it costs to get to... put $1 million in, get
$10 million out. I know what that is already. So, if I'm fully funded, then I'll
be able to forecast, but not until. And there's no way of me knowing yet if I'm
going to be fully-funded--I know I'll be funded, but I don't know if I'll be
fully funded.
Scott: Okay. So, after the S-1, whether it's fully funded or partially funded, you
intend to project out and say "Given the money that I have, here's what I
think would be."
Joe: That's what most public companies do when they have revenue, yeah. That's
typically the game plan.
Scott: Alright. Well, if you feel that anything is... the rubber has hit the road and
there's an announcement worthy of making, if this process takes longer than
you think, then we'd appreciate hearing that.
Joe: Well, listen, I'm sure we'll be having another conference call soon... and I've
never seen anyone do as many as we do... so, we're right at the end here.
We've got to get the S-1 filed as I'm saying, got to get funding; once we're
funded, then we turn on the pieces that we acquired with no money--or hardly
any money--and then away we go and build the enterprise and deliver the
going concern.
Scott: Alright. Well, thanks for your time, Joe. Good luck on that S-1 then, it sounds
like that's the--
Joe: Well, keep your eyes open, it should be filed within the next week or ten days
for sure. Done--I can tell you it's done, but filing it is a different story
sometimes.
Scott: Great. Thanks a lot, Joe.
Joe: Thank you very much.
I found this interaction to be the most poignant that joe was in.....as he was pressed to give projections of sales, that don't exist yet, and how he manuevered to NOT ANSWER the question, no matter what....
page 31-33 of conference call on the 29 th of Nov, 2019
hear me out, and if you don't want to do it, fine--if you were to take your
existing footprint on Excellagen, where you're approved to sell what you
think you're going to sell in 2020. If that number were a thousand vials of 3
cc at 5700 gross margin and you were to put out a PR Monday saying, "We
think our 2020 bare minimum Excellagen sales are going to be this," and
there was a number like a thousand of those at 5700 bucks gross margin, I'd
go out and celebrate--and a lot of other people would too.
Joe: Well, you know what companies do that? Are companies on the OTC that are a sham company, that typically do things like that. I cannot, in good
conscience, do anything like that unless I'm fully funded, unless these
companies get the necessary dollars to fully execute on their plan or...
[crosstalk] Until that happens, I am not going to hypotheticalize on what
potential sales could be.
Scott: I'm not asking for hypotheticals. You are stocking your shelves with a
product, correct? You have said you have sales from Excellagen, correct?
You have that manufactured...
Joe: Again, as of right now, that would be very hard for me to gauge because I
don't... am I going to have--you tell me, am I going to have 20 VAs with the
money, am I going 50 VAs...?
Scott: That was what I'm saying, just tell us, "Worst case... here's what we’ve
gotten..."
Joe: I can't tell give that to you.
Scott: You don't have to tell me now, but if I have an asset that I'm producing for a
company that is not able to... where else are we producing revenues?
Joe: Listen, I appreciate what you're trying to make me do, but I'm not going to
hypotheticalize what we could do based upon so many different variables at
this point. I'd like to get the money in, full-funded, and then I'll project based
upon having all the money necessary to give you what you want in a forecast.
Scott: Okay. So, how long after we get the S-1 through do you think that would
happen, that we'd see something that says, "Here's what we're projecting."?
You've said that you think 250 million--
Joe: I don't know... it would be a guess. I don't know. How long will the STC take
to review the S-1 and then render it effective? I don't know.
Scott: No, I'm saying once you have the S-1, the 40 to 70 million is in the bank, do
you think that you'll put out a projection in X weeks, X months after...
Joe: If we are fully funded, I would out projections pretty immediately, because
then I know--I know already what it costs to get to... put $1 million in, get
$10 million out. I know what that is already. So, if I'm fully funded, then I'll
be able to forecast, but not until. And there's no way of me knowing yet if I'm
going to be fully-funded--I know I'll be funded, but I don't know if I'll be
fully funded.
Scott: Okay. So, after the S-1, whether it's fully funded or partially funded, you
intend to project out and say "Given the money that I have, here's what I
think would be."
Joe: That's what most public companies do when they have revenue, yeah. That's
typically the game plan.
Scott: Alright. Well, if you feel that anything is... the rubber has hit the road and
there's an announcement worthy of making, if this process takes longer than
you think, then we'd appreciate hearing that.
Joe: Well, listen, I'm sure we'll be having another conference call soon... and I've
never seen anyone do as many as we do... so, we're right at the end here.
We've got to get the S-1 filed as I'm saying, got to get funding; once we're
funded, then we turn on the pieces that we acquired with no money--or hardly
any money--and then away we go and build the enterprise and deliver the
going concern.
Scott: Alright. Well, thanks for your time, Joe. Good luck on that S-1 then, it sounds
like that's the--
Joe: Well, keep your eyes open, it should be filed within the next week or ten days
for sure. Done--I can tell you it's done, but filing it is a different story
sometimes.
Scott: Great. Thanks a lot, Joe.
Joe: Thank you very much.
I found this interaction to be the most poignant that joe was in.....as he was pressed to give projections of sales, that don't exist yet, and how he manuevered to NOT ANSWER the question, no matter what....
page 31-33 of conference call on the 29 th of Nov, 2019
(0)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼